Summary:
- Lorient Capital, a healthcare-focused investment firm in Miami, closed its Lorient Healthcare Fund III with $500M in total commitments.
- The fund closed on June 30th and will support founder-led healthcare companies in the middle market with operational expertise.
- Lorient’s investment strategy focuses on sectors experiencing growth, such as consumer-directed healthcare and tech-enabled services.
Article:
Lorient Capital, headquartered in Miami, recently announced the successful closure of its Lorient Healthcare Fund III, securing a total of $500M in commitments. This milestone, reached on June 30th, marks a significant achievement for the firm as it prepares to implement its strategic investment approach in the healthcare sector.Led by Co-Managing Partners David Berman and Jordan Broome, Lorient specializes in partnering with founder-led healthcare companies within the middle market. Their unique value proposition lies in providing sector-specific knowledge, hands-on operational support, and a proven methodology for scaling mission-driven enterprises.
The firm’s investment focus centers on sectors undergoing significant transformation and growth, including consumer-directed healthcare, post-acute care, behavioral health, provider enablement, and tech-enabled services. Lorient’s operational model is designed to enhance performance and drive value creation in these dynamic areas of the healthcare industry.
Over the years, Lorient has successfully completed 20 platform investments and more than 75 add-on acquisitions. The firm’s track record of nine realized exits underscores its ability to build, scale, and unlock value across its diverse portfolio of healthcare ventures.
With the launch of Fund III, Lorient remains committed to supporting high-quality management teams in scaling healthcare businesses that combine operational excellence with a strong clinical focus. The firm’s continued dedication to fostering growth and innovation in the healthcare space positions it as a key player in driving sustainable success for its portfolio companies.
In conclusion, Lorient Capital’s successful fundraising for Fund III underscores its commitment to advancing the healthcare sector through strategic investments and operational expertise. As the firm continues to identify new opportunities and support emerging healthcare leaders, its impact on the industry is poised to grow even further in the coming years.
